Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate-Reference-Cited by-同舟云学术

Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidate

Published:2003-06 Issue:19-20 Volume:21 Page:2651-2660
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Plotnicky Hélène,Siegrist Claire-Anne,Aubry Jean-Pierre,Bonnefoy Jean-Yves,Corvaı̈a Nathalie,Nguyen Thien Ngoc,Power Ultan F

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference36 articles.

1. Collins PL, McIntosh K, Chanock RM. Respiratory syncytial virus. In: Knipe DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott-Raven; 1996. p. 1313–51.

2. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine;Kim;Am. J. Epidemiol.,1969

3. A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology;Gershwin;Vaccine,1998

4. A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine;Kakuk;J. Infect. Dis.,1993

5. Animal models of respiratory syncytial virus infection;Byrd;Clin. Infect. Dis.,1997

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Respiratory Syncytial Virus F Subunit Vaccine With AS02 Adjuvant Elicits Balanced, Robust Humoral and Cellular Immunity in BALB/c Mice;Frontiers in Immunology;2020-09-11

2. Up-to-date role of biologics in the management of respiratory syncytial virus;Expert Opinion on Biological Therapy;2020-04-17

3. Neonatal priming and infancy boosting with a novel respiratory syncytial virus vaccine induces protective immune responses without concomitant respiratory disease upon RSV challenge;Human Vaccines & Immunotherapeutics;2019-10-30

4. Original Antigenic Sin and Respiratory Syncytial Virus Vaccines;Vaccines;2019-09-06

5. Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity;Frontiers in Immunology;2019-03-26